Vaccinum morbillorum, parotitidis et rubellae vivum

Medicinal product name M-M-RVAXPRO
Pharmaceutical form Powder and solvent for suspension for injection
Strength  
Information from the MAH on shortages Not available
predicted availability date: not notified
Legal status Rx Prescription (Pr.)
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code J07BD52 Vaccines

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: not notified
currently no information on availability from any wholesaler N1
(0,5 ml)
Glass vial and vial    EU/1/06/337/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/06/337/001
Date of authorisation May 5, 2006
Marketing authorisation holder, country MSD Vaccins, France